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of all the symptomatic osteoarthritis involve the 
knee. A study conducted in Malang showed that the 
issues of OA in Indonesia may be greater compared 
to those in western countries. More than 85% of 
OA patients in Indonesia have activity impairment, 
especially during squatting, going up and down 
the stairs, and walking. Those are crucial activities 
performed in the daily life of the Indonesian 
people.6
Health-related quality of life is defi ned by 
Cella and Tulsky as the perception of one’s current 
functional capacity and satisfaction compared 
to that one expects. Health-related quality of 
life is an abstract variable. Basically, there are 
two components of quality of life: subjective 
expression/perception and objective component.4 
The objective data measured is the health status of a 
person.5,7 The subjective expression is more diffi cult 
to measure but could still be measured indirectly by 
using a questionnaire. The respondent’s answer is 
then converted into score that could be measured 
objectively.4
One of the commonly used questionnaires 
of quality of life is the European Quality of Life 
5 Dimension (EQ-5D), which was constructed 
by the British-based EuroQol Group. EQ-5D is 
designed such that it could be fi lled out by the 
respondent him/herself because it contains easy-
to-follow instructions. It could be used for postal 
questionnaire, self-administered response in the 
clinic, and direct interview. EQ-5D is simple 
and only needs a few minutes to fi ll out. EQ-5D 
contains two sheets. The fi rst sheet consists of 
the 5 dimensions of measurement: mobility, self-
care, usual activity, pain/discomfort, and anxiety/
depression. Each dimension has 3 levels of scoring: 
no problem, some problems, or extreme problems. 
The second EQ-5D sheet contains the visual 
analogue scale (VAS) to describe the subject’s 
perception about his/her quality of life using a 
particular scale.6
EQ-5D has been translated into various 
languages and used in various countries. Studies of 
EQ-5D in OA has previously been done, such as by 
Brazier et al8 in 1993 in England and by Fransen 
ABSTRACT
Background:  Quality of life is very important to 
knee osteoarthritis (OA) patients. The term quality 
of life denotes one that is health-related. One of the 
questionnaires most frequently used to measure the 
quality of life is the European Quality of Life 5-Dimension 
(EQ-5D) questionnaire. At Cipto Mangunkusumo General 
Hospital, until today there has not been any instrument 
for measuring the health-related quality of life in knee 
OA patients that has been tested for its reliability and 
validity.
Objective:  To prove the reliability and validity of EQ-
5D as a measurement tool in determining the health-
related quality of life in knee OA patients at Cipto 
Mangunkusumo General Hospital.
Methods:  This is a validity study in which all patients 
were asked to complete both the EQ-5D form and 36-
item short form (SF-36) on their fi rst visit. They were 
subsequently asked again to complete only the EQ-5D 
form one week after their fi rst visit.
Results:  Data were obtained from 86 respondents. 
The value of the intraclass correlation coeffi cient of each 
EQ-5D dimension, EQ-5D index, and visual analogue 
scale (VAS) was excellent (>0.75). Cronbach’s α value 
for internal consistency reliability in this study was 
0.6772 (<0.7). The external validity of EQ-5D compared 
to SF-36 was analyzed with the Pearson’s correlation 
test and revealed a signifi cant correlation (p<0.01) of 
all EQ-5D dimensions, EQ-5D index, and EQ-5D VAS 
with total score of SF-36 except for the dimensions of 
self-care, pain, and anxiety/depression. The construct 
validity of EQ-5D showed that all of the dimensions were 
signifi cantly correlated with the EQ-5D index (p<0.01) 
except for self-care dimension.
Conclusion:  EQ-5D is a valid and reliable measurement 
tool. It is thus recommended for measuring the health-
related quality of life in knee OA patients at Cipto 
Mangunkusumo General Hospital.
Osteoarthritis (OA) is a common joint disease and 
is one of the causes of disability and pain.1–3 This 
disease often attacks the weight-supporting joints 
such as the knee, hip, and backbone.1,3,4 According 
to a study conducted by Cushnaghan et al,5 41.2% 
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et al9 in 1999 in Sydney; both confi rmed the reliability and 
validity of EQ-5D. Until today, Indonesia has not performed 
a study of reliability and validity of EQ-5D as a measurement 
tool of health-related quality of life in knee osteoarthritis 
patients.
This study is aimed at proving that EQ-5D is a reliable and 
valid measurement tool to determine health-related quality 
of life of knee OA patients at Cipto Mangunkusumo General 
Hospital.
METHODS
This is a validation study using consecutive method, which 
involved all OA patients aged above 50 years old who visited 
the rheumatology clinic at Cipto Mangunkusumo General 
Hospital, Jakarta from March 2007 until May 2007. The 
inclusion criteria were knee OA patients who fulfi lled the 
clinical and radiographic criteria based on the American 
College of Rheumatology (ACR) criteria and have Kellgren-
Lawrence score of >2 (mild, moderate, or severe OA) and 
willing to participate in the study. The exclusion criteria were 
coexisting dementia, aphasia, and psychosis.
Necessary data were collected by performing anamnesis, 
physical examination, plain radiograph of the knee (if both 
knees suffer from OA, assessment was conducted on the more 
severe one), and completing the EQ-5D and 36-item short form 
(SF-36) questionnaires. After one week, respondents were 
again asked to fi ll the EQ-5D questionnaire. Intraobserver and 
internal consistency of each EQ-5D dimension for reliability 
was assessed using intraclass correlation coeffi cient (ICC) and 
Cronbach’s α coeffi cient (Cα). External validity (the average 
of each EQ-5D and SF-36 component) was assessed using 
the Pearson’s correlation coeffi cient. Construct validity was 
assessed using correlation formula.
RESULTS
Characteristics of the respondents
There were 86 respondents enrolled in the study, consisting 
of 73 females and 13 males. The mean age of the respondents 
was 58.22 years old, in which the oldest was 77 years old. 
Most (51.2%) of the respondents were homemakers, followed 
by entrepreneurs/small business owners (20.9%). Most 
(41.9%) had only grade school education, while 29.1% had a 
high school degree.
Reliability 
In this study we used intraobserver test-retest and internal 
consistency to assess reliability. Intraobserver test-retest is the 
degree of agreement of the outcome of the study conducted 
by the same observer during the fi rst visit and the visit one 
week after. Intraobserver test-retest to assess reliability was 
measured using ICC. The value ranges between 0 and 1, in 
which <0.4 means weak correlation, 0.4–0.75 means good 
correlation, and >0.75 means excellent correlation.10
The reliability outcome of EQ-5D could be seen in table 
1. All the ICC values were >0.75, which indicated that the 
correlation was excellent and therefore reliability was 
excellent.
Table 1   Intraobserver test-retest for reliability of European 
Quality of Life 5 Dimension (EQ-5D)






Each item of the measurement tool must correlate with 
each other. This is called internal consistency and is measured 
using the Cronbach’s α with values ranging from 0 to 1. 
Internal consistency of EQ-5D for assessing reliability in this 
study showed Cronbach’s α value of 0.6772, which indicated 
that EQ-5D had reliability with a low level of confi dence.
Validity 
In the external validity, EQ-5D was compared to SF-36 using 
the Pearson’s correlation coeffi cient test to obtain the r value. 
Table 2 shows the correlation between EQ-5D and SF-36.
In table 2, we could see that the EQ-5D index and EQ-
5D VAS had signifi cant correlation with SF-36 total score 
(p<0.01). Some scores of each EQ-5D dimension and SF-36 
also had signifi cant correlation (p<0.01).
A signifi cant correlation indicated that there was either 
positive or negative correlation. A positive correlation means 
that the higher the score of a dimension, the higher the score is 
of the other dimension, i.e. the correlation of the EQ-5D index 
with total SF-36. From table 2, the r value = 0.293, meaning 
that the higher the score of EQ-5D index, the higher is the 
scores of SF-36. A more detailed correlation between the two 
are visualized in fi gure 1.
A signifi cant negative correlation, for example, is the 
correlation between the dimensions of mobility, usual activity, 
pain/discomfort, anxiety in EQ-5D and the total score of SF-
36. The basic idea that must be understood is that in EQ-5D 
the best score is 1. A score of 3 indicates many problems; 
therefore the lower the score of the mobility dimension in EQ-
5D, the higher is the total score of SF-36.
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Table 2   Pearson’s correlation coeffi cients between European Quality of Life 5 Dimension (EQ-5D) and Short Form-36 (SF-36)
EQ-5D







r −0.163 −0.144 −0.185 −0.076 −0.303** −0.178 0.409**
p −0.134 −0.186 −0.88 −0.487 −0.005 −0.101 0.000
Role-physical r −0.345** −0.011 −0.559** −0.182** −0.294** −0.230* 0.353**
p −0.001 −0.919 −0.000 −0.093 −0.006 −0.033 0.001
Bodily pain r −0.378** −0.036 −0.461** −0.238* −0.089 −0.290** 0.222*
p −0.000 −0.739 −0.000 −0.028 −0.415 −0.007 0.04
General health r −0.19 −0.004 −0.043 −0.191 −0.012 −0.193 0.04
p −0.079 −0.968 −0.695 −0.078 −0.914 −0.076 0.717
Vitality r −0.187 −0.245* −0.106 −0.082 −0.073 −0.145 0.244*
p −0.085 −0.023 −0.33 −0.455 −0.506 −0.184 0.024
Social functioning r −0.152 −0.219* −0.177 −0.148 −0.122 −0.126 0.082
p −0.163 −0.043 −0.103 −0.173 −0.246 −0.249 0.451
Role-emotional r −0.226* −0.143 −0.365** −0.08 −0.031 −0.152 0.230*
p −0.036 −0.191 −0.001 −0.464 −0.78 −0.164 0.033
Mental health r −0.042 −0.183 −0.101 −0.064 −0.061 −0.021 0.131
p −0.699 −0.092 −0.354 −0.559 −0.577 −0.85 0.23
Total score r −0.377** −0.093 −0.526** −0.220* −0.231* −0.293** 0.436**
p −0.000 −0.392 −0.000 −0.041 −0.033 −0.006 0.000
*A signifi cant correlation existed at p<0.05; **A signifi cant correlation existed at p<0.01.
VAS, visual analogue scale.
Figure 1 and 2 gives a clearer description of the correlation 
between EQ-5D and SF-36. Figure 1 shows the correlation 
between EQ-5D index and total SF-36 with an r value of 
0.293. Figure 2 shows the correlation between EQ-5D VAS 
and total SF-36 with r value of 0.436.
Figure 1   Correlation between European Quality of Life 5 Dimension 
(EQ-5D) index and total 36-item short form (SF-36) scores.
Figure 2   Correlation between European Quality of Life 5 Dimension 
visual analog scale (EQ-5D VAS) and total 36-item short form
(SF-36) scores.
Table 3 shows the construct validity of EQ-5D. The EQ-5D 
dimensions were compared with the scores of EQ-5D index 
using the Pearson’s correlation test to obtain the r value. 
The result showed that the EQ-5D dimensions of mobility, 
usual activity, pain/ discomfort, and anxiety were signifi cantly 
correlated with EQ-5D index (p<0.01). All the EQ-5D 
dimensions had negative correlation with EQ-5D index.
Except for the self-care dimension, the EQ-5D dimensions 
had r (absolute) value of >0.3. Kline11 had determined the r 
value to be = 0.3 in assessing the validity of the psychometric 
measurement tool; thus all the EQ-5D dimensions were 
clinically correlated with the EQ-5D index.
Table 3   Pearson’s correlation coeffi cients between each 
European Quality of Life 5 Dimension (EQ-5D) dimension and EQ-
5D index
EQ-5D dimensions EQ-5D index
Mobility −0.684  (0.000)
Self-care −0.166  (0.126)
Usual activity −0.401  (0.000)
Pain/discomfort −0.858  (0.000)
Anxiety/depression −0.631  (0.000)
All values are r (p value).
Health-related quality of life
In this study, we obtained the scores of health-related quality 
of life of knee OA patients. The details could be seen in table 
4.
Table 4   The scores of European Quality of Life 5 Dimension (EQ-
5D) index, EQ-5D visual analogue scale (EQ-5D VAS), and total 
Short Form-36 (SF-36) (N = 86)
Mean  (SD) Range
Total SF-36 59.461  (12.506) 34.17–82.50
EQ-5D index   0.734  (0.162)   0.124–1
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The distribution of respondents according to the EQ-
5D index could be seen in fi gure 3. There were 15.1% of 
respondents who had EQ-5D index score of 1 (maximum) and 
2.3% who had the lowest EQ-5D index score of 0.124.
Figure 3  The distribution of European Quality of Life 5 Dimension 
(EQ-5D) index scores.
The outcome of EQ-5D of each dimension is presented in 
table 5. Most respondents (ranging between 22.1 and 93%) 
had no problem (score of 1) for the mobility dimension (EQ1), 
self-care (EQ2), usual activity (EQ3) and anxiety/depression 
(EQ5). Most (75.6%) respondents experienced moderate 
pain/discomfort (score 2) for the pain/discomfort dimension 
(EQ4).
The total score in the assessment of quality of life using SF-
36 was 59.461 of the possible scores between 34.17 and 82.50. 
The dimension with the highest score (72.093) was the social 
functioning dimension while the bodily pain dimension had 
the lowest score (42.78). The physical component summary 
was the mean of the physical functioning, role limitations 
due to physical health problems (role-physical), bodily pain, 
general health, and social functioning with a value of 54.9093 
(SD 13.8065). The mental component summary was the mean 
of the general health, social functioning, role limitations due 
to emotional problems (role-emotional), and mental health 
with a value of 67.373 (SD 11.7586). Further details could be 
seen in table 6.
Table 6   The score of each 36-item short form (SF-36) 
dimension (N = 86)
Mean  (SD) Range
Physical functioning 56.92  (21.19) 15–95
Role-physical 47.38  (38.16)   0–100
Bodily pain 42.78  (15.52) 12–72
General health 55.49  (11.05) 10–100
Vitality 71.98  (16.26) 25–82
Social functioning 72.093  (17.328) 30–95
Role-emotional 59.054  (28.891) 37.50–100
Mental health 59.054  (16.59)   0–100
Physical component summary 54.9093  (13.8065) 28.2–79.4
Mental component summary 67.373  (11.7586) 45.8–94.25
Total score 59.461  (12.506) 34.17–95
DISCUSSION
This is a validity study with respondents consisting of knee 
OA patients whose ages ranged from 50 to 77 years old and 
had educational background ranging from grade school to 
associate degree. There was a variety of occupations. Female 
patients outnumbered male patients. The above distribution 
of respondents could represent the heterogeneity of the study 
population. We did not fi nd any other chronic diseases, such as 
diabetes mellitus, hypertension, or asthma during this study.
Reliability was assessed using intraobserver test-retest and 
internal consistency. There has not yet any study conducted 
to assess the reliability of EQ-5D using ICC and Cronbach’s 
α of knee OA patients. Studies that had been conducted so far 
was the evaluation of ICC in rheumatoid arthritis, stroke, the 
elderly, and general population.9,13–18 Fransen et al9 compared 
the reliability and validity of the EuroQol (EQ-5D) in knee 
OA patients with Western Ontario and McMaster Universities 
(WOMAC) index, OA index, and SF-36 and found reliability 
and construct validity of EQ-5D with an ICC value of 0.70 
with a confi dence level (95% CI) of 0.58–0.80 and test-retest 
analysis of each EQ-5D dimension with a correlation between 
0.28 (p = 0.008) for mobility and 0.60 (p = 0.001) for anxiety/
depression. The study revealed that the ICC value was 0.70; 
however, internal consistency using Cronbach’s α was not 
evaluated.
As a comparison, the following are studies using ICC 
to determine the reliability of EQ-5D. A study conducted 
in Zimbabwe with respondents from the general population 
using EQ-5D in the local Shona language showed an ICC 
value of >0.75 in the dimensions of mobility and usual activity 
and between 0.4 and 0.75 for the dimension of self-care, pain/
discomfort and anxiety/depression.19 A study of EQ-5D in 
stroke patients conducted by Dorman et al15 found that the ICC 
for mobility dimension and EQ-5D index was >0.75 while in 
other dimensions it was between 0.4 and 0.75. Hurst et al13 
conducted a study of EQ-5D in rheumatoid arthritis patients 
and found that the ICC of EQ-5D index and EQ-5D VAS 
was >0.75. The three studies found that EQ-5D had good to 
excellent intraobserver reliability and there was no bad ICC 
value (<0.4). Harmaini17 found that the ICC value ranged from 
0.611 to 0.936 with the highest ICC value for mobility and the 
lowest value for anxiety/depression while the Cronbach’s α 
was in the elderly population.
We conducted an intraobserver test-retest instead of the 
interobserver test because the assessment and the measurement 
tool were performed by the respondents. The interobserver 
test is performed if the measurement tool that will be tested 
needs the evaluation from the researcher, for example in 
measuring the blood pressure using a manometer, reading 








Table 5   The score of each European Quality of Life 5 Dimension (N = 86)
EQ1, mobility EQ2, self-care EQ3, usual activity EQ4, pain/discomfort EQ5, anxiety/depression
Score 1, no problem 43  (50) 80  (93) 49  (57) 19  (22.1) 48  (55.8)
Score 2, some problems 43  (50)   6  (7) 37  (43) 65  (75.6) 38  (44.2)
Score 3, extreme problems   0  (0)   0  (0)   0  (0)   2  (2.3)   0  (0)
All values are n (%).
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the interobserver test had been conducted in this study, the 
outcome would have been different from the intraobserver 
test because of the cognitive differences between those of the 
respondents and those of the observers.
The Cronbach’s α value of the internal consistency 
reliability of this study was 0.6772. The use of internal 
consistency to evaluate the EQ-5D reliability is still debatable. 
Some authors state that it is not needed but others, such as 
Velarde-Jurado et al,20 stated that EQ-5D internal consistency 
could be performed although he did not report the Cronbach’s 
α value in his article. The Cronbach’s α value obtained in this 
study was <0.7, indicating that EQ-5D in knee OA patients 
had a low level of confi dence.21–23
The low level of confi dence of Cronbach’s α value in this 
study was caused by various factors: the anxiety/depression 
dimension was not always present in knee OA respondents, and 
self-care and pain dimension did not affect the daily activities 
of the knee OA patients. Because of the various factors above, 
a low Cronbach’s α value did not indicate that EQ-5D had a 
low reliability. By passing two reliability tests—ICC value of 
EQ-5D was from good to excellent and Cronbach’s α value 
was of low confi dence level—we can say that the Indonesian 
version of EQ-5D had reliability to measure the health-related 
quality of life in knee OA patients with ICC ranging from 
0.883 to 0.907 and Cronbach’s α of 0.6772. 
The validity of EQ-5D to measure health-related quality of 
life in knee OA patients in this study was assessed using two 
methods: external validity by comparing EQ-5D and SF-36 of 
the Indonesian version, and the construct validity of EQ-5D. 
In Great Britain, EQ-5D and SF-36 had been proven 
valid for measuring the health-related quality of life in the 
elderly. SF-36 was also used to measure the quality of life in 
Indonesia.14,21–25
We analyzed the external validity of EQ-5D compared 
to SF-36 by using the Pearson’s correlation coeffi cient test 
and found a signifi cant correlation (p<0.01) that included the 
correlation between the EQ-5D dimension, EQ-5D index with 
SF-36 dimension and total score of SF-36. The correlation test 
for EQ-5D VAS with the physical function dimension and the 
SF-36 role-physical, or SF-36 total score also had signifi cant 
correlation (p<0.01).
Such type of validation method, comparing one 
questionnaire with another, is commonly used to assess the 
validity of the quality of life questionnaire, including the 
questionnaire for knee OA patients. For example, Fransen et 
al9 compared EQ-5D, WOMAC, and SF-36.
A similar study had been conducted by Brazier et al8 in 
Great Britain in 1993, who studied the validity of EuroQol of 
the general population by comparing it with SF-36. EuroQol 
was a questionnaire similar to EQ-5D but with one additional 
question: family activity. They obtained a similar outcome, in 
which EuroQol had signifi cant correlation with SF-36 with the 
exception of the correlation of SF-36 mental health dimension 
with EuroQol mobility and self-care dimension.
From the above data, comparing EQ-5D with SF-36 could 
be used as a mean to assess the external validity of EQ-5D; 
thereby we could say that the EQ-5D form has external validity 
to measure the quality of life of knee OA patients.
The construct validity in this study was conducted by 
fi nding the correlation of values of each dimension with the 
EQ-5D index score. Ancok26 stated that this is a permissible 
method to determine construct validity. Ohinmaa et al27 also 
used the same method to measure the health-related quality of 
life of the elderly in Finland.
The EQ-5D construct was tested using Pearson’s correlation 
test, which showed that EQ-5D had a good construct. All EQ-
5D dimensions were signifi cantly correlated with EQ-5D 
index (p<0.01). A study in Finland conducted by Ohinmaa et 
al27 obtained the same result, in which all EQ-5D dimensions 
were correlated with EQ-5D index.
By passing the two methods of validity test, this study 
proved that the EQ-5D form is a valid measurement tool 
to measure the health-related quality of life of knee OA 
patients.
The EQ-5D form could be used to assess health-related 
quality of life. In this study we could see an example of 
assessment of health-related quality of life of knee OA patients 
in table 4, table 5, and fi gure 2 in further detail.
The mean value of health-related quality of life of knee 
OA patients in this study using EQ-5D index was 0.734 and 
the mean value of EQ-5D VAS was 71.98. Below are studies 
from other countries for comparison. Fransen et al9 in Australia 
in 1999 conducted a reliability and validity study of knee OA 
patients above 50 years old and found that the mean value of 
EQ-5D index was 0.58 and EQ-5D VAS was 71.3. Ohinmaa 
et al27 in Finland in 2001 conducted a survey of health-related 
quality of life of a general population of above 75 years old 
and found that the mean EQ-5D index was 0.67 and EQ-5D 
VAS  was 51. Brazier et al16 in Great Britain in 1996 found that 
the mean EQ-5D index was 0.61 and the EQ-5D VAS was 68 
in the female population of above 75 years old. Kind et al28 in 
1998 studied the health-related quality of life using EQ-5D in 
the general population and found that the mean EQ-5D VAS 
of those above 80 years old was 72. Badia et al29 found that the 
value of EQ-5D VAS was 60.6 in those aged above 65.
The value of EQ-5D index in this study was higher than 
the ones of other countries. This is because the respondents 
in this study were patients of knee OA who must also had 
suffered from chronic diseases and have adapted to the 
Indonesian sociocultural environment while the respondents 
in the studies conducted in other countries were knee OA 
sufferers in the community with or without comorbidity and 
had a sociocultural environment that was different from that 
in Indonesia.30–33
The value of EQ-5D VAS in this study was similar to that 
in a study conducted by Fransen et al9 in Australia.
We must note that in the assessment of the quality of life, 
it is diffi cult to determine whether the level of one’s quality of 
life is better or worse than that of another by only comparing 
the outcome of one study with another.
Quality of life is dynamic and infl uenced by many 
factors.34–43 When we use the EQ-5D index or EQ-5D VAS to 
assess the quality of life of an individual/society, it is better to 
evaluate the change of values rather than evaluate the value at 
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one point of time.
Although the score of EQ-5D index in this study was 
higher and the EQ-5D VAS was almost the same as those of 
other countries, the health-related quality of life in Indonesia 
is not always better than of those in other countries. Further 
studies are needed to obtain the data of quality of life of knee 
OA patients in Indonesia.
Kline11 determined that the value of r = 0.3 was the level 
of correlation coeffi cient that could be accepted to assess the 
validity of a questionnaire if there are not any measurement 
tools as a gold standard to measure a variable. In Indonesia 
there has not been any gold standard to measure the health-
related quality of life of knee OA patients. 
The result in this study showed that the value of r 
(absolute) of all the EQ-5D dimensions was above 0.3. This 
indicated that all the EQ-5D dimensions could be used for 
clinical applications to determine the quality of life of knee 
OA patients.
The EQ-5D index had signifi cant correlation with the 
SF-36 pain dimension and SF-36 total score while EQ-5D 
VAS was correlated with the SF-36 dimensions of physical 
functioning, role-physical, and SF-36 total score.
In clinical practice, if there is a difference in the scores of 
EQ-5D index and EQ-5D VAS (for example, if the EQ-5D 
index is maximum (score of 1) and EQ-5D VAS is only 50), 
the EQ-5D index is more reliable as the value of health-related 
quality of life since the value of health-related quality of life 
using VAS is the subjective expression of an individual and is 
infl uenced by cognitive factors.44
CONCLUSIONS
EQ-5D is a reliable tool to measure the health-related quality 
of life of knee OA patients in Cipto Mangunkusumo General 
Hospital. EQ-5D has internal consistency at a low level of 
confi dence with Cronbach’s α value of 0.6772, has construct 
validity with a weak correlation, and good external validity.
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